Launca Medical Snags ￥10M in Series B Round

According to PEdaily.cn, Guangzhou-based medical technology company Launca Medical has raised tens of millions of yuan in a Series B round, led by Shenzhen Guozhong Venture Capital Management ("Guozhong Venture Capital"). Proceeds of this fund will be used to buy the equity of overseas companies, build a processing center, develop new products, and build a training team.

Founded in October 2013, Launca Medical is a high-tech company of R&D, production and sales of Class II oral devices and materials including intraoral scanners and optical powder, focusing on independent innovations, industrialization and marketing promotion of digital oral equipment and materials. The company is committed to providing "one-stop" dental services and digital solutions from intra-oral scanning to the denture making for the global oral market.

Lu Jian, founder and CEO of Launca Medical, graduated from Tsinghua University with a bachelor's degree and a PhD from California Institute of Technology and has nearly 20 years of experience in the research and commercialization of 3D imaging and oral health industry. According to Lu Jian, DL-100 developed by Launca Medical, is the first self-developed intra-oral scanning product in China.

Pang Changwei, director of Guozhong Venture Capital, said, "Digitalization is the inevitable trend of development in oral health. China has a high prevalence of oral diseases with a low rate of consultation and high potential demand. Launca Medical has been focusing on the needs of clinical optimization iteration products in the past few years. It is going to build a  closed loop of digital oral services and provide an overall solution with high performance and low cost."

Founded in December 2015, Guozhong Venture Capital is currently being entrusted to manage the first entity fund of Small Medium Enterprises Development Fund（Shenzhen）LLP with a size of 6 billion yuan.

Guozhong Venture Capital with a registered size of 100 million yuan, partners consisting of Shenzhen Venture Capital Group (49%) and the management team of Small Medium Enterprise Development Fund (Shenzhen) (51%).